RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Huadong Medicine Co Stock

Huadong Medicine Co Net Income 2024

Huadong Medicine Co Net Income

3.36 B CNY

Ticker

000963.SZ

ISIN

CNE0000011S1

In 2024, Huadong Medicine Co's profit amounted to 3.36 B CNY, a 18.27% increase from the 2.84 B CNY profit recorded in the previous year.

The Huadong Medicine Co Net Income history

YEARNET INCOME (undefined CNY)
2027e6.41
2026e4.41
2025e3.85
2024e3.36
20232.84
20222.5
20212.3
20202.82
20192.81
20182.27
20171.78
20161.45
20151.1
20140.76
20130.58
20120.47
20110.38
20100.32
20090.38
20080.19
20070.17
20060.1
20050.07
20040.03

Huadong Medicine Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Huadong Medicine Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Huadong Medicine Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Huadong Medicine Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Huadong Medicine Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Huadong Medicine Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Huadong Medicine Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Huadong Medicine Co’s growth potential.

Huadong Medicine Co Revenue, EBIT and net profit per share

DateHuadong Medicine Co RevenueHuadong Medicine Co EBITHuadong Medicine Co Net Income
2027e56.25 B undefined7.92 B undefined6.41 B undefined
2026e51.2 B undefined5.53 B undefined4.41 B undefined
2025e47.56 B undefined4.84 B undefined3.85 B undefined
2024e43.91 B undefined4.19 B undefined3.36 B undefined
202340.62 B undefined3.67 B undefined2.84 B undefined
202237.71 B undefined3.19 B undefined2.5 B undefined
202134.56 B undefined2.9 B undefined2.3 B undefined
202033.68 B undefined3.17 B undefined2.82 B undefined
201935.45 B undefined3.33 B undefined2.81 B undefined
201830.66 B undefined2.93 B undefined2.27 B undefined
201727.83 B undefined2.37 B undefined1.78 B undefined
201625.38 B undefined1.89 B undefined1.45 B undefined
201521.73 B undefined1.55 B undefined1.1 B undefined
201418.95 B undefined1.27 B undefined757 M undefined
201316.72 B undefined1.02 B undefined575 M undefined
201214.58 B undefined889 M undefined470 M undefined
201111.13 B undefined690 M undefined381 M undefined
20108.97 B undefined502 M undefined317 M undefined
20097.83 B undefined574 M undefined379 M undefined
20086.02 B undefined360 M undefined189 M undefined
20074.85 B undefined358 M undefined173 M undefined
20063.97 B undefined213 M undefined97 M undefined
20053.48 B undefined173 M undefined67 M undefined
20042.88 B undefined114 M undefined31 M undefined

Huadong Medicine Co stock margins

The Huadong Medicine Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Huadong Medicine Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Huadong Medicine Co.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Huadong Medicine Co's sales revenue. A higher gross margin percentage indicates that the Huadong Medicine Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Huadong Medicine Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Huadong Medicine Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Huadong Medicine Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Huadong Medicine Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Huadong Medicine Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Huadong Medicine Co Margin History

Huadong Medicine Co Gross marginHuadong Medicine Co Profit marginHuadong Medicine Co EBIT marginHuadong Medicine Co Profit margin
2027e32.38 %14.09 %11.4 %
2026e32.38 %10.8 %8.62 %
2025e32.38 %10.18 %8.09 %
2024e32.38 %9.55 %7.65 %
202332.38 %9.04 %6.99 %
202231.89 %8.46 %6.63 %
202130.65 %8.4 %6.66 %
202033.04 %9.4 %8.37 %
201932.06 %9.39 %7.94 %
201828.98 %9.57 %7.39 %
201726.12 %8.5 %6.4 %
201624.27 %7.46 %5.7 %
201523.97 %7.13 %5.05 %
201421.96 %6.71 %4 %
201320.17 %6.08 %3.44 %
201219.51 %6.1 %3.22 %
201119.21 %6.2 %3.42 %
201018.5 %5.6 %3.53 %
200919.48 %7.34 %4.84 %
200819.13 %5.98 %3.14 %
200721 %7.38 %3.56 %
200619.71 %5.37 %2.44 %
200517.88 %4.97 %1.92 %
200416.93 %3.96 %1.08 %

Huadong Medicine Co Aktienanalyse

What does Huadong Medicine Co do?

Huadong Medicine Co Ltd is a leading pharmaceutical company headquartered in Hangzhou, China. It was founded in 1989 and has since become one of the most significant players in the research, development, production, and distribution of medical products in China. History In its early years, the company started as a manufacturer of simple pharmaceutical products, namely painkillers and dermatological products. However, Huadong Medicine soon focused on the production of innovative medications and equipped itself with modern technological facilities and processes. Today, the company specializes in this field and tirelessly works on the development and production of high-quality medications and medical devices. Business Model Huadong Medicine operates according to a holistic business model that focuses on the well-being of people. To achieve this, the company combines research, development, and production, allowing it to offer innovative solutions for various patient needs. Additionally, the company emphasizes the rapid market introduction of new products and the efficient marketing of its offerings. Segments Huadong Medicine operates in several different segments, including: - Pharmaceutical Products - Medical Devices and Equipment - Medical Foods The pharmaceutical products comprise the development and production of medicines such as antibiotics, painkillers, vitamins, as well as treatments for hypertension, diabetes, and cancer. Medical devices and equipment are used to provide healthcare services, including disposable and reusable needles, syringes, and surgical instruments. Medical foods include dietary supplements and technologies for producing foods with functional properties. Products Huadong Medicine offers a wide range of products that meet the needs of people in different parts of the world. These include: - Antibiotics such as Amoxicillin and Clavulanic Acid - Painkillers such as Ibuprofen and Paracetamol - Vitamins such as Vitamin C, B1, B2, and B5, as well as multivitamins - Hypertension treatments such as Telmisartan and Ramipril - Diabetes treatments such as Metformin and Glibenclamide - Cancer treatments such as Paclitaxel and Zoledronic Acid - Disposable and reusable needles and surgical instruments - Dietary supplements such as Ginseng Extract and Glucosamine Conclusion Huadong Medicine is a company that is committed to helping people with its products. Over the years, the company has worked hard to improve its performance in the areas of research, development, production, and distribution of medical products. Today, it takes pride in being one of the top companies in the field of medical products and solutions in China. Huadong Medicine Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Huadong Medicine Co's Profit Margins

The profit margins of Huadong Medicine Co represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Huadong Medicine Co's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Huadong Medicine Co's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Huadong Medicine Co's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Huadong Medicine Co’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Huadong Medicine Co stock

How much profit has Huadong Medicine Co made this year?

Huadong Medicine Co has made 3.36 B CNY this year.

How has the profit developed compared to last year?

The profit has increased by 18.27% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Huadong Medicine Co publish its earnings?

Huadong Medicine Co publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Huadong Medicine Co?

The profits of Huadong Medicine Co are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Huadong Medicine Co?

You can learn more about the earnings of Huadong Medicine Co by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Huadong Medicine Co pay?

Over the past 12 months, Huadong Medicine Co paid a dividend of 0.29 CNY . This corresponds to a dividend yield of about 0.8 %. For the coming 12 months, Huadong Medicine Co is expected to pay a dividend of 0.32 CNY.

What is the dividend yield of Huadong Medicine Co?

The current dividend yield of Huadong Medicine Co is 0.8 %.

When does Huadong Medicine Co pay dividends?

Huadong Medicine Co pays a quarterly dividend. This is distributed in the months of July, July, June, October.

How secure is the dividend of Huadong Medicine Co?

Huadong Medicine Co paid dividends every year for the past 14 years.

What is the dividend of Huadong Medicine Co?

For the upcoming 12 months, dividends amounting to 0.32 CNY are expected. This corresponds to a dividend yield of 0.89 %.

In which sector is Huadong Medicine Co located?

Huadong Medicine Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Huadong Medicine Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Huadong Medicine Co from 9/20/2024 amounting to 0.35 CNY, you needed to have the stock in your portfolio before the ex-date on 9/20/2024.

When did Huadong Medicine Co pay the last dividend?

The last dividend was paid out on 9/20/2024.

What was the dividend of Huadong Medicine Co in the year 2023?

In the year 2023, Huadong Medicine Co distributed 0.29 CNY as dividends.

In which currency does Huadong Medicine Co pay out the dividend?

The dividends of Huadong Medicine Co are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Huadong Medicine Co

Our stock analysis for Huadong Medicine Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Huadong Medicine Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.